Cue Biopharma, Inc. (CUE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 2.2300 |
| Open | 2.2000 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 1400 |
| Day's Range | 2.2000 - 2.4900 |
| 52 Week Range | 2.1800 - 5.1200 |
| Volume | |
| Avg. Volume | 417,534 |
| Market Cap | 106.104M |
| Beta (5Y Monthly) | 2.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1900 |
| Earnings Date | Nov 13, 2023 - Nov 17, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.00 |
GlobeNewswireCue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®
Completed enrollment of patient expansion cohort of 20 patients at the RP2D of 4 mg/kg in combination with KEYTRUDA® (pembrolizumab) in first line (1L) refractory/metastatic HPV+ Head and Neck Cancer patientsData to date from CUE-101 in combination with pembrolizumab demonstrates more than double the historical ORR of pembrolizumab alone, including patients with tumors of low PD-L1 expressionUpdated data from both the combination and monotherapy trials will be presented at the 2023 Society for I
- Thomson Reuters StreetEvents
Q2 2023 Cue Biopharma Inc Earnings Call
Q2 2023 Cue Biopharma Inc Earnings Call
Simply Wall St.Investors in Cue Biopharma (NASDAQ:CUE) have unfortunately lost 83% over the last three years
Every investor on earth makes bad calls sometimes. But really bad investments should be rare. So spare a thought for...
© 2023 Yahoo. All rights reserved.
